Neurocognitive Risk With PCSK9 Inhibitors

被引：3
|
作者：
Khan, Abdur Rahman [1 ]
Riaz, Haris [1 ]
Farid, Talha [1 ]
Bolli, Roberto [1 ]
机构：
[1] Univ Louisville, Dept Med, Div Cardiovasc Med, 200 Abraham Flexner Way, Louisville, KY 40202 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 19期
基金：
美国国家卫生研究院;
关键词：
CARDIOVASCULAR EVENTS; REDUCING LIPIDS; SAFETY; ALIROCUMAB; EFFICACY;
D O I：
10.1016/j.jacc.2017.02.063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2468 / 2469
页数：3
相关论文
共 50 条
  • [21] Do PCSK9 inhibitors reduce cardiovascular events?
    Kolber, Michael R.
    Nickonchuk, Tony
    Turgeon, Ricky
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (09) : 669 - 669
  • [22] PCSK9 inhibitors. Recommendations for patient selection
    Laufs, U.
    Custodis, F.
    Werner, C.
    HERZ, 2016, 41 (04) : 296 - 306
  • [23] Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
    Volkova, S. Yu.
    Boyarskaya, L. A.
    Toropygin, P. Yu.
    Morozov, I. A.
    Boyarskaya, E. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (01) : 43 - 49
  • [24] PCSK9 Inhibitors: Lots of Work Done, Lots More to Do
    Lauer, Michael S.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (09) : 624 - 625
  • [25] Neurocognitive Impairment in Cardiovascular Disease Patients Taking Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: A Systematic Review
    Shahid, Rabia
    Naik, Shaili S.
    Ramphall, Shivana
    Rijal, Swarnima
    Prakash, Vishakh
    Ekladios, Heba
    Saju, Jiya Mulayamkuzhiyil
    Mandal, Naishal
    Kham, Nang I.
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [26] So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients
    McNutt, Markey C.
    Ahmad, Zahid
    CIRCULATION-CARDIOVASCULAR GENETICS, 2015, 8 (06) : 749 - 751
  • [27] Limitations of cholesterol lowering with PCSK9 inhibitors
    Thompson, Gilbert
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (04) : 241 - 243
  • [28] Role of PCSK9 inhibitors in the management of dyslipidaemia
    Nair, Tiny
    INDIAN HEART JOURNAL, 2024, 76 : S44 - S50
  • [29] PCSK9 Inhibitors Current clinical Relevance
    Vogt, A.
    INTERNIST, 2017, 58 (02): : 196 - 201
  • [30] PCSK9 inhibitors - past, present and future
    Reiner, Zeljko
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1517 - 1521
12345